日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized Placebo-Controlled Trial Assessing the Effect of 24-Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME -2 Trial.

随机安慰剂对照试验评估 24 周非诺贝特治疗对腹主动脉瘤循环标志物的影响:FAME-2 试验的结果

Pinchbeck Jenna L, Moxon Joseph V, Rowbotham Sophie E, Bourke Michael, Lazzaroni Sharon, Morton Susan K, Matthews Evan O, Hendy Kerolos, Jones Rhondda E, Bourke Bernie, Jaeggi Rene, Favot Danella, Quigley Frank, Jenkins Jason S, Reid Christopher M, Velu Ramesh, Golledge Jonathan

Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial.

非诺贝特治疗腹主动脉瘤(FAME):一项随机对照试验的研究方案

Rowbotham Sophie E, Cavaye Doug, Jaeggi Rene, Jenkins Jason S, Moran Corey S, Moxon Joseph V, Pinchbeck Jenna L, Quigley Frank, Reid Christopher M, Golledge Jonathan